Type IA variation for application Roszdravnadzor-2021-0059. Type IA variation: New Dosage Strength for Atezolimumab-R — critical change

Variation Number
Roszdravnadzor-2021-0059-V359
Type
Type IA
Status
Completed
Fee
€4,982
Submitted
2023-08-21
Approved
—
Description

Type IA variation: New Dosage Strength for Atezolimumab-R — critical change